SCHEMBL4618261

SCHEMBL4618261

CN(C)CCNS(=O)(=O)c1cccc(S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 2/20 0.62
TSHR P16473 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 1/20 0.46
PKM P14618 1/20 0.46
HTR6 P50406 1/20 0.46
PRMT1 Q99873 1/20 0.46
ATM Q13315 1/20 0.46
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4618353 0.92 SFRP1 (0.73) SFRP1KMT2AALDH1A1KDM4ELMNA
SCHEMBL3143577 0.86 NPSR1 (0.70) SFRP1TSHRNPSR1ALDH1A1KDM4E
SCHEMBL4617938 0.86 SIGMAR1 (0.57) SFRP1TSHRKMT2AALDH1A1KDM4E
SCHEMBL4618147 0.85 SFRP1 (0.71) SFRP1TSHRNPSR1ALDH1A1SMN1; SMN2
SCHEMBL1348562 0.82 ATM (0.62) TSHRNPSR1KMT2AALDH1A1ATM
SCHEMBL12282399 0.82 KMT2A (0.76) TSHRNPSR1KMT2AALDH1A1CA12
SCHEMBL4616427 0.81 SFRP1 (0.60) SFRP1KMT2AALDH1A1KDM4ELMNA
SCHEMBL2850682 0.81 PRMT1 (0.61) TSHRNPSR1KMT2AALDH1A1LMNA
Hydrochloric Acid SCHEMBL7966569 0.81 ATM (0.61) TSHRNPSR1KMT2AALDH1A1ATM
SCHEMBL26731607 0.80 CYP2C19 (0.70) TSHRNPSR1KMT2AALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101208299-A Diarylsulfone sulfonamides and use therof WYETH CORP (US) 2008-06-25 CN claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
CN-101208299-A Diarylsulfone sulfonamides and use therof WYETH CORP (US) 2008-06-25 CN disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885TSHR 3611/4885NPSR1 634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.